Published in Cell Commun Signal on January 05, 2017
Oxidants, oxidative stress and the biology of ageing. Nature (2000) 23.21
The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev (2007) 21.13
Free radicals in the physiological control of cell function. Physiol Rev (2002) 19.62
Nitric oxide and peroxynitrite in health and disease. Physiol Rev (2007) 15.49
NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol (2004) 12.93
Uric acid and cardiovascular risk. N Engl J Med (2008) 12.20
Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A (1981) 8.45
Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol Rev (2008) 5.74
Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension (2003) 5.47
Hyperuricemia induces endothelial dysfunction. Kidney Int (2005) 5.36
Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension (2001) 4.41
A role for uric acid in the progression of renal disease. J Am Soc Nephrol (2002) 3.77
Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol (2005) 3.73
Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol (2008) 3.42
Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension (2003) 3.39
Uric acid and oxidative stress. Curr Pharm Des (2005) 2.75
Hyperglycemic pseudohypoxia and diabetic complications. Diabetes (1993) 2.62
Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension (2002) 2.47
Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension (2004) 2.46
Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol (1992) 2.35
New insights into the epidemiology of gout. Rheumatology (Oxford) (2009) 2.21
Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol (2005) 2.07
Nitric oxide and redox mechanisms in the immune response. J Leukoc Biol (2011) 1.97
von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res (1997) 1.83
Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med (2001) 1.82
Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol (2003) 1.79
Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers. Diabetes (2006) 1.79
Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids (2008) 1.76
Is there anything good in uric acid? QJM (2011) 1.75
Altered uric acid levels and disease states. J Pharmacol Exp Ther (2007) 1.73
The missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl (2000) 1.69
von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost (2006) 1.61
Inactivation of nitric oxide by uric acid. Nucleosides Nucleotides Nucleic Acids (2008) 1.59
Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells. Am J Physiol Cell Physiol (2008) 1.53
Fyn and p38 signaling are both required for maximal hypertonic activation of the osmotic response element-binding protein/tonicity-responsive enhancer-binding protein (OREBP/TonEBP). J Biol Chem (2002) 1.51
Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation (2000) 1.45
Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int Suppl (2000) 1.41
SnapShot: Reactive Oxygen Intermediates (ROI). Cell (2010) 1.35
Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats. Diabetes (2003) 1.34
Renal transport of uric acid: evolving concepts and uncertainties. Adv Chronic Kidney Dis (2012) 1.26
Central role for aldose reductase pathway in myocardial ischemic injury. FASEB J (2004) 1.19
Retracted Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells. FASEB J (1997) 1.18
Uric acid and evolution. Rheumatology (Oxford) (2010) 1.17
Aldose reductase enzyme and its implication to major health problems of the 21(st) century. Curr Med Chem (2009) 1.16
Comparison of uric acid and ascorbic acid in protection against EAE. Free Radic Biol Med (2002) 1.05
Aldose reductase inhibitors improve myocardial reperfusion injury in mice by a dual mechanism. J Pharmacol Sci (2006) 1.05
Aldose reductase: a novel therapeutic target for inflammatory pathologies. Int J Biochem Cell Biol (2009) 1.00
Serum uric acid levels correlate with plasma hydrogen peroxide and protein carbonyl levels in preeclampsia. Am J Hypertens (2008) 1.00
Aldose reductase inhibition improves altered glucose metabolism of isolated diabetic rat hearts. Am J Physiol (1998) 0.98
ALDOSE REDUCTASE: New Insights for an Old Enzyme. Biomol Concepts (2011) 0.96
Uric acid promotes left ventricular diastolic dysfunction in mice fed a Western diet. Hypertension (2014) 0.95
Reactions of peroxynitrite with uric acid: formation of reactive intermediates, alkylated products and triuret, and in vivo production of triuret under conditions of oxidative stress. Nucleosides Nucleotides Nucleic Acids (2009) 0.94
Hyperuricemia induces endothelial dysfunction via mitochondrial Na+/Ca2+ exchanger-mediated mitochondrial calcium overload. Cell Calcium (2012) 0.94
Uric acid increases fibronectin synthesis through upregulation of lysyl oxidase expression in rat renal tubular epithelial cells. Am J Physiol Renal Physiol (2010) 0.92
Hydrogen peroxide: watery fuel for change in vascular biology. Arterioscler Thromb Vasc Biol (2006) 0.92
Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure? Med Hypotheses (2007) 0.92
Serum uric acid and 1-h postload glucose in essential hypertension. Diabetes Care (2011) 0.90
Role of uric acid as an endogenous radical scavenger and antioxidant. Chest (1991) 0.89
Exercise training restores coronary arteriolar dilation to NOS activation distal to coronary artery occlusion: role of hydrogen peroxide. Arterioscler Thromb Vasc Biol (2007) 0.86
Higher circulating levels of uric acid are prospectively associated with better muscle function in older persons. Mech Ageing Dev (2008) 0.86
Nucleotide sequence and deduced amino acid sequence of a Plasmodium falciparum actin gene. Mol Biochem Parasitol (1988) 0.86
Uric acid modulates vascular endothelial function through the down regulation of nitric oxide production. Free Radic Res (2012) 0.84
Inflammatory pathways. Contrib Nephrol (2011) 0.84
Attenuation of ischemia induced increases in sodium and calcium by the aldose reductase inhibitor zopolrestat. Cardiovasc Res (1999) 0.82
Uric acid administration for neuroprotection in patients with acute brain ischemia. Med Hypotheses (2004) 0.82
Aldose reductase from human tissues. Methods Enzymol (1982) 0.81
Endothelial nitric oxide synthase uncoupling: Is it a physiological mechanism of endothelium-dependent relaxation in cerebral artery? Cardiovasc Res (2006) 0.81
Aldose reductase inhibitor ameliorates renal vascular endothelial growth factor expression in streptozotocin-induced diabetic rats. Yonsei Med J (2010) 0.81
Improvement of renal oxidative stress markers after ozone administration in diabetic nephropathy in rats. Diabetol Metab Syndr (2010) 0.80
Genetic deficiency of aldose reductase counteracts the development of diabetic nephropathy in C57BL/6 mice. Diabetologia (2011) 0.79
ALDR enhanced endothelial injury in hyperuricemia screened using SILAC. Cell Physiol Biochem (2014) 0.79
Adenoviral-mediated overexpression of catalase inhibits endothelial cell proliferation. Am J Physiol Heart Circ Physiol (2002) 0.79
The effect of uric acid on homocysteine-induced endothelial dysfunction in bovine aortic endothelial cells. Neuro Endocrinol Lett (2009) 0.78
[Activity of enzymes of glutathione metabolism and regulation by cAMP in human tumors]. Vopr Onkol (1987) 0.76
Increased plasma endothelin level as an endothelial marker of cardiovascular risk in patients with active acromegaly: a comparison with plasma homocysteine. Methods Find Exp Clin Pharmacol (2009) 0.76